NextGen General Pvt. Ltd.

, ,

0.5mg Mylimus Tacrolimus Capsule

165.00

Manufacturer Mylan
Indication Kidney Transplant
Release Form Immediate Release
Packaging Type 6×10 Capsules
Treatment Used To Prevent Organ Rejection In Transplant Patients.
Pack Type Box
Strength 0.5 mg
Composition Tacrolimus

Mylimus 0.5 Capsule – Overview

Mylimus 0.5 Capsule contains Everolimus (0.5 mg), an immunosuppressant medication primarily used to prevent organ rejection in patients undergoing kidney or liver transplantation. It works by inhibiting the activity of the immune system, reducing the risk of rejection and improving transplant success. Additionally, Everolimus is also used in certain cancer treatments due to its ability to block tumor growth.

Benefits of Mylimus 0.5 Capsule:

  • Prevents Organ Rejection: Helps in preventing the immune system from attacking transplanted kidneys or liver.
  • Cancer Treatment Support: Used in some cancer therapies to slow tumor growth and enhance patient outcomes.
  • Targeted Action: Works by inhibiting mTOR, a key protein involved in immune response and cell growth.
  • Convenient Oral Dosage: Easy-to-take capsule form ensures better patient compliance.
  • Trusted Manufacturer: Produced by Mylan Pharmaceuticals, ensuring high-quality standards and global regulatory compliance.

Specification/Additional Details:

  • Strength: 0.5 mg
  • Packaging Type: Blister Pack
  • Packaging Size: 10 capsules per strip
  • Brand: Mylimus
  • Manufactured By: Mylan Pharmaceuticals
  • Country of Origin: India

For bulk orders, pricing, and further inquiries, please contact us.

Reviews

There are no reviews yet.

Be the first to review “0.5mg Mylimus Tacrolimus Capsule”

Your email address will not be published. Required fields are marked *

Scroll to Top